Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Sesen Bio reaches deal with investor group, paving way for Carisma merger
3 years ago
Financing
Deals
A Texas-based biotech becomes the latest to enter the SPAC scene
3 years ago
Financing
Deals
With a year full of readouts ahead, Disc Medicine secures cash from Bain Capital
3 years ago
R&D
Updated: FDA adds warning of 'larger areas of bleeding' in brain to Biogen's Aduhelm label
3 years ago
FDA+
FDA hands down RTF letter to rare disease biotech's lead candidate
3 years ago
R&D
FDA+
GSK revises Covid deal with Vir, pulls out of next-gen work
3 years ago
Deals
R&D
Harvard professor takes on the mantle of Gavi CEO
3 years ago
People
PROTACs to RIPTACs: Arvinas founder snags $76M for next bet, Halda Therapeutics
3 years ago
Financing
Startups
Replay partners with MD Anderson’s Katy Rezvani, heads to clinic with new TCR NK cell company
3 years ago
Financing
Startups
John Reed lands in the top R&D post at J&J in his latest Big Pharma debut
3 years ago
People
Bioregnum
Should Narcan spray be sold over the counter? FDA poses potential packaging changes
3 years ago
Pharma
FDA+
US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case
3 years ago
Pharma
Law
Sun Pharma issues recall for more than 34,000 bottles of blood pressure medication
3 years ago
Pharma
FDA+
Gilead's Kite clues patients in with conversational CAR-T cell therapy campaign
3 years ago
Pharma
Marketing
FDA rejects Biocon and Viatris' Avastin biosimilar after inspection question marks
3 years ago
Pharma
FDA+
Operation Warp Speed for rare diseases: CBER leader says pilot is coming soon
3 years ago
FDA+
Incyte says under-the-radar JAK inhibitor clears a high bar for skin disorder
3 years ago
R&D
Vivek Ramaswamy planning a run for US president — report
3 years ago
People
Giving first glimpse of data, Scancell looks for Covid-19 vaccine partner
3 years ago
R&D
Coronavirus
Third time’s the charm: Cerevance’s Series B expands again
3 years ago
Financing
Startups
Frequency Therapeutics reports trial fail and lays off over half of staff — stock capsizes
3 years ago
R&D
G1 Therapeutics abandons PhIII colorectal cancer trial after disappointing overall response rates
3 years ago
R&D
Updated: Sorrento files for Chapter 11 after losing arbitration to Patrick Soon-Shiong biotech
3 years ago
Pharma
Sanofi’s R&D chief John Reed makes surprise exit
3 years ago
People
First page
Previous page
376
377
378
379
380
381
382
Next page
Last page